Cell Counting Market by Product (Instruments (Spectrophotometer, Hemocytometer, Flow Cytometer, Hematology Analyzers), Consumables (Reagent, Microplate)), Cancer, Stem Cell Research, End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2025
“The growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, and the development of enhanced solutions & improved image analysis will drive market growth.”
The global cell counting market is estimated to reach USD 14.5 billion by 2025 from USD 10.4 billion in 2020, at a CAGR of 6.7% during the forecast period. Market growth is largely driven by growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers. On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.
“The research application segment commanded the largest share of the market in 2019.”
On the basis of application, the cell counting market is segmented into research, medical, and industrial applications. In 2019, research applications accounted for the largest share of the market. Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment.
“The research institutes segment commanded the largest share of the cell counting market in 2019.”
On the basis of end users, the cell counting market is segmented into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users. In 2019, research institutes accounted for the largest share of the market. The large share of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical companies.
“The Asia Pacific region to register the highest growth in the global cell count market during the forecast period.”
The Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the growing number of proteomics, genomics, and stem cell research activities; increasing research funding; increasing investments by pharmaceutical and biotechnology companies; and the growing trend of research infrastructure modernization are supporting market growth in the Asia Pacific.
In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other directors, and executives from various key organizations operating in the cell count market.
By Respondent Type: Supply Side (70%) and Demand Side (30%)
By Designation: Managers (55%), CXOs (20%), and Executives (25%)
By Region: North America (45%), Europe (25%), APAC (20%), LATAM (5%), and MEA (5%)
The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US)
The study includes an in-depth competitive analysis of these key players in the cell counting market, along with their company profiles, recent developments, and key market strategies.
The market study covers the cell counting market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on product, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall cell count market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights so as to better position their businesses, and to plan suitable go-to-market strategies. The report will also help stakeholders to understand the pulse of the market and provide information on the key market drivers, restraints, opportunities, and challenges.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook